Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study
Objectives To describe the incidence of adverse events (AEs), reactogenicity symptoms, menstrual changes and overall self-rated improvement in health and well-being after COVID-19 vaccination.Design VAC4COVID is an ongoing prospective, active observational, post-authorisation cohort safety study (PA...
Saved in:
Main Authors: | Thomas M MacDonald, Andrew Duncan, Amy Rogers, Greg Guthrie, Alex Doney, Steve Morant, Isla Mackenzie, Evelien Rooke, Rebecca Barr, Filippo Pigazzani, Krists Zutis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e060583.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01) -
Vaccination schemes and CoronaVac: Are there differences between adults and older adults hospitalized by COVID-19?
by: María Kappes, et al.
Published: (2023-08-01) -
CoronaVac-induced antibodies that facilitate Fc-mediated neutrophil phagocytosis track with COVID-19 disease resolution
by: Chuang Li, et al.
Published: (2025-12-01) -
Genome stability of the vaccine strain VAC∆6
by: R. A. Maksyutov, et al.
Published: (2022-07-01) -
Interim Singapore guidelines for basic and advanced life support for paediatric patients with suspected or confirmed COVID-19
by: Gene Yong-Kwang Ong, et al.
Published: (2022-08-01)